EUVIMEDEUVIMED entdecken
Crossref

AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer

Kaichun Li, Ping Dai, Jian Li, Long Liu, Shiyu Cheng, Qingliang Fang, Bingxiang Wu

The Journal of Gene Medicine · 2024

DOI: 10.1002/jgm.3661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Kaichun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Signal Transduction, Chromosomal Proteins, Non-Histone, Cell Cycle Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Special Project of Clinical Research of Health Industry of Shanghai Municipal Health Commission, Scientific Research Project of Hongkou District Health Committee of Shanghai, Research Project of Shanghai Fourth People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Upregulation of SMC1A (Structural maintenance of chromosomes 1A) is linked with many types of cancer and its oncogenic function, which has been associated with crucial cellular mechanisms (cell division, cell cycle checkpoints regulation and DNA repair). Recent studies have shown that SMC1A was involved in breast cancer, although the exact mechanisms of SMC1A remain to be determined.

Methods

Using The Cancer Genome Atlas (TCGA) database, we examined SMC1A expression and its relation to other genes, including FOXM1 and STMN1. Short hairpin RNA was used to subsequently examine the biological roles of SMC1A in MDA‐MB‐231 and MDA‐MB‐468 cell lines. Bioinformatics were performed to identify the SMC1A‐related gene FOXM1.

Results

Here, we used the TCGA database to show that SMC1A is overexpressed in breast cancer. Later investigations showed SMC1A's role in breast cancer cell survival, apoptosis and invasion. Using bioinformatics and western blot assays, we confirmed that FOXM1 acted as the downstream of SMC1A, and SMC1A knockdown significantly downregulated the FOXM1 expression via the AKT signal pathway. Interestingly, the inhibition effects induced by SMC1A downregulation could be reversed by FOXM1 overexpression. In the clinic, SMC1A expression is favorably linked with FOXM1 expression in breast cancer tumor tissues.

Conclusions

Collectively, our results not only enhance our knowledge of SMC1A's molecular pathways in breast cancer, but also suggest a potential new therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSignal TransductionChromosomal Proteins, Non-HistoneCell Cycle ProteinsFemaleHumansCell Cycle CheckpointsCell Line, TumorCell ProliferationForkhead Box Protein M1Gene Expression Regulation, NeoplasticProto-Oncogene Proteins c-aktStathminStructural Maintenance of Chromosome Protein 1

Stichwörter der Autor:innen

FOXM1SMC1Aapoptosisbreast cancercell proliferation

Substanzen

Forkhead Box Protein M1FOXM1 protein, humanProto-Oncogene Proteins c-aktStathminSTMN1 protein, humanStructural Maintenance of Chromosome Protein 1Chromosomal Proteins, Non-HistoneCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Oncology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Oncology, Tianyou Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Radiation Oncology, LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Förderung

  • Special Project of Clinical Research of Health Industry of Shanghai Municipal Health Commission
  • Scientific Research Project of Hongkou District Health Committee of Shanghai
  • Research Project of Shanghai Fourth People's Hospital

Zitieren

APA

Li, K., Dai, P., Li, J., Liu, L., Cheng, S., Fang, Q., & Wu, B. (2024). AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3661

Vancouver

Li K, Dai P, Li J, Liu L, Cheng S, Fang Q, et al. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3661

BibTeX
@article{Li2024,
  author = {Li, Kaichun and Dai, Ping and Li, Jian and Liu, Long and Cheng, Shiyu and Fang, Qingliang and Wu, Bingxiang},
  title = {AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer},
  journal = {The Journal of Gene Medicine},
  year = {2024},
  doi = {10.1002/jgm.3661}
}
Kostenlos starten →